Interaction of New, Very Potent Non-Nucleotide Antagonists with Arg256 of the Human Platelet P2Y12 Receptor

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2009-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.109.156687PMID 19690189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.

  2009cited by this paper
• Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.

  2009cited by this paper
• P2 receptors, platelet function and pharmacological implications

  2008cited by this paper
• Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)

  2008cited by this paper
• Interaction of the active metabolite of prasugrel, R‐138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor

  2008cited by this paper
• Development of selective agonists and antagonists of P2Y receptors

  2008cited by this paper
• Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists.

  2008cited by this paper
• Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.

  2008cited by this paper
• Structure and ligand-binding site characteristics of the human P2Y11 nucleotide receptor deduced from computational modelling and mutational analysis.

  2007cited by this paper
• From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

  2007cited by this paper
• Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile.

  2007cited by this paper
• Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives.

  2007cited by this paper
• Platelet P2 receptors: old and new targets for antithrombotic drugs

  2007cited by this paper
• International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy

  2006cited by this paper
• The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts.

  2006cited by this paper
• Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.

  2006cited by this paper
• Pharmacological profiles of cloned mammalian P2Y-receptor subtypes

  2006cited by this paper
• Structure-activity relationships of novel P2-receptor antagonists structurally related to Reactive Blue 2.

  2005cited by this paper
• Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.

  2005cited by this paper
• Central role of the P2Y12 receptor in platelet activation.

  2004cited by this paper
• Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding

  2003cited by this paper
• Constitutional isomers of Reactive Blue 2 - selective P2Y-receptor antagonists?

  2003cited by this paper
• Evidence for the recognition of non‐nucleotide antagonists within the transmembrane domains of the human P2Y1 receptor

  2002cited by this paper
• P2Y-Receptors Mediating an Inhibition of the Evoked Entry of Calcium through N-Type Calcium Channels at Neuronal Processes

  2002cited by this paper
• Antiplatelet action of R‐99224, an active metabolite of a novel thienopyridine‐type Gi‐linked P2T antagonist, CS‐747

  2001cited by this paper
• An arginine/glutamine difference at the juxtaposition of transmembrane domain 6 and the third extracellular loop contributes to the markedly different nucleotide selectivities of human and canine P2Y11 receptors.

  2001cited by this paper
• Identification and Biological Activity of the Active Metabolite of Clopidogrel

  2000cited by this paper
• Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.

  1999cited by this paper
• The Role of Amino Acids in Extracellular Loops of the Human P2Y1 Receptor in Surface Expression and Activation Processes*

  1999cited by this paper
• A mutational analysis of residues essential for ligand recognition at the human P2Y1 receptor.

  1997cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Site-directed Mutagenesis of P2U Purinoceptors

  1995cited by this paper
• Differential effects of P2‐purinoceptor antagonists on phospholipase C‐ and adenylyl cyclase‐coupled P2Y‐purinoceptors

  1994cited by this paper
• Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release.

  1993cited by this paper
• P2‐purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y‐ but not the P2x‐purinoceptor

  1987cited by this paper

• P2Y12 Receptor Function Governs Microglial Surveillance and Cell–Cell Interactions in the Cerebral Cortex

  2025cites this paper
• P2Y receptors in GtoPdb v.2025.3

  2025cites this paper
• Drug-like Antagonists of P2Y Receptor Subtypes: An Update

  2025cites this paper
• Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes.

  2024cites this paper
• Microglial TNFα controls daily changes in synaptic GABAARs and sleep slow waves

  2024cites this paper
• Pharmacological characterization of P2Y receptor subtypes – an update

  2023cites this paper
• Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats

  2023cites this paper
• Strategies for targeting the P2Y12 receptor in the Central Nervous System.

  2022cites this paper
• New Perspectives for Antiplatelet Therapy: The Evolution of P2Y12 Receptor Antagonists

  2021cites this paper
• Recommended tool compounds and drugs for blocking P2X and P2Y receptors

  2021cites this paper
• Central inhibition of P2Y12R differentially regulates survival and neuronal loss in MPTP-induced Parkinsonism in mice

  2021cites this paper
• The dualistic role of the purinergic P2Y12-receptor in an in vivo model of Parkinson's disease: signalling pathway and novel therapeutic targets.

  2021cites this paper
• P2Y receptors in GtoPdb v.2021.3

  2021cites this paper
• The role of purinergic P2Y12 and P2Y13 receptors in ADPβS-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats

  2020cites this paper
• Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y1 and P2Y12 as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor.

  2020cites this paper
• Update of P2Y receptor pharmacology: IUPHAR Review 27

  2020cites this paper
• Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets.

  2020cites this paper
• Molecular Pharmacology of P2Y Receptor Subtypes.

  2020cites this paper
• Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?

  2019cites this paper
• Pharmacology of P2Y receptors.

  2019cites this paper
• Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery.

  2019cites this paper
• Constitutive P2Y2 receptor activity regulates basal lipolysis in human adipocytes

  2018cites this paper
• P2Y12-dependent modulation of ADP-evoked calcium responses in human monocytes

  2018cites this paper
• Tools and drugs for uracil nucleotide‐activated P2Y receptors

  2018cites this paper
• P2Y2 and P2Y6 receptor activation elicits intracellular calcium responses in human adipose-derived mesenchymal stromal cells

  2018cites this paper
• [PSB0739 inhibits formation of semen-derived amyloid fibril].

  2018cites this paper
• Rapid and accurate assessment of GPCR–ligand interactions Using the fragment molecular orbital‐based density‐functional tight‐binding method

  2017cites this paper
• Microglial Ramification, Surveillance, and Interleukin-1β Release Are Regulated by the Two-Pore Domain K+ Channel THIK-1

  2017cites this paper
• Structure, Pharmacology and Roles in Physiology of the P2Y12 Receptor.

  2017cites this paper
• Contribution of platelet P2Y12 receptors to chronic Complete Freund's adjuvant‐induced inflammatory pain

  2017cites this paper
• Development of Potent and Selective Antagonists for the UTP-Activated P2Y4 Receptor.

  2017cites this paper
• Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor.

  2016cites this paper
• Drug-like Antagonists of P2Y Receptors-From Lead Identification to Drug Development.

  2016cites this paper
• Anthraquinones as a privileged scaffold in drug discovery targeting nucleotide-binding proteins.

  2016cites this paper
• Pharmacology and structure of P2Y receptors.

  2016cites this paper
• Antiplatelet Agents Inhibit the Generation of Platelet-Derived Microparticles

  2016cites this paper
• State of affairs: Design and structure-activity relationships of reversible P2Y12 receptor antagonists.

  2016cites this paper
• Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information

  2015cites this paper
• Purinergic signalling in the enteric nervous system (An overview of current perspectives).

  2015cites this paper
• Targeting renal purinergic signalling for the treatment of lithium‐induced nephrogenic diabetes insipidus

  2015cites this paper
• Blood cells: an historical account of the roles of purinergic signalling

  2015cites this paper
• Rare platelet GPCR variants: what can we learn?

  2015cites this paper
• P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.

  2015cites this paper
• Ecto-nucleotidase inhibitors: recent developments in drug discovery.

  2015cites this paper
• Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12‐receptor

  2014cites this paper
• pain and cytokine production in rodents

  2014cites this paper
• Therapeutic Potentials of Ecto‐Nucleoside Triphosphate Diphosphohydrolase, Ecto‐Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto‐5′‐Nucleotidase, and Alkaline Phosphatase Inhibitors

  2014cites this paper
• Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents

  2014influential citation
• P2X and P2Y nucleotide receptors as targets in cardiovascular disease.

  2013cites this paper
• Efficient and mild deamination procedure for 1-aminoanthraquinones yielding a diverse library of novel derivatives with potential biological activity

  2012cites this paper
• G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions

  2012cites this paper
• Convergent Synthesis of the Potent P2Y Receptor Antagonist MG 50-3-1 Based on a Regioselective Ullmann Coupling Reaction

  2012cites this paper
• P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential.

  2012cites this paper
• Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.

  2012cites this paper
• P2Y purinoceptors as potential emerging therapeutical target in vascular disease.

  2012cites this paper
• Development of a comprehensive set of P2 receptor pharmacological research compounds

  2011cites this paper
• Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor.

  2011cites this paper
• Pharmacochemistry of the platelet purinergic receptors

  2011cites this paper
• Comparison of three GPCR structural templates for modeling of the P2Y12 nucleotide receptor

  2011cites this paper
• Molecular pharmacology, physiology, and structure of the P2Y receptors.

  2011influential citation
• Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions

  2010cites this paper
• P2X and P2Y Receptors

  2010cites this paper
• P2Y nucleotide receptors: promise of therapeutic applications.

  2010cites this paper
• Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.

  2010cites this paper